Xiao Shuai

Chengdu, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Chengdu, CN 

Overview

Xiao Shuai practices practicing medicine in Chengdu, China.

Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Leukemia, and Hemophagocytic Lymphohistiocytosis.

She is actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Chengdu, China
Other Locations
Jiujiang, 332000, China
Key Laboratory Of Modern Preparation Of Traditional Chinese Medicine, State Key Lab Of Innovation Drug And Efficient Energy Saving Pharmaceutical Equipment, Nanchang, China
China
Changsha, 410008, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Single-arm, Pivotal Registration Phase II Study of the Efficacy and Safety of APG-2575 Monotherapy in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
A Single-arm, Pivotal Registration Phase II Study of the Efficacy and Safety of APG-2575 Monotherapy in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Enrollment Status: Recruiting
Publish Date: March 27, 2026
Intervention Type: Drug
Study Drug: APG2575
Study Phase: Phase 2

36 Total Publications

Platelet Hyperreactivity May Contribute to Thrombotic Complications in Afibrinogenemia: A Case-Based Observation.
Platelet Hyperreactivity May Contribute to Thrombotic Complications in Afibrinogenemia: A Case-Based Observation.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: April 17, 2026

Frequently Asked Questions about Xiao Shuai

Is Xiao Shuai a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Xiao Shuai is classified as an Experienced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xiao Shuai participate in research or clinical trials?

Yes. Xiao Shuai has published 36 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Xiao Shuai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Shuai's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile